| Trial ID: | L7192 |
| Source ID: | NCT00283777
|
| Associated Drug: |
Chromium Picolinate
|
| Title: |
Chromium and Insulin Action
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes
|
| Interventions: |
DRUG: Chromium Picolinate
|
| Outcome Measures: |
Primary: Insulin Senstivity, glycated hemoglobin | Secondary: weight, body composition
|
| Sponsor/Collaborators: |
Sponsor: Pennington Biomedical Research Center
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
30
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT
|
| Start Date: |
1998-08
|
| Completion Date: |
2003-04
|
| Results First Posted: |
|
| Last Update Posted: |
2016-04-08
|
| Locations: |
University of Vermont, Burlington, Vermont, 05410, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00283777
|
